TDRD9
Basic information
Region (hg38): 14:103928456-104052667
Previous symbols: [ "C14orf75" ]
Links
Phenotypes
GenCC
Source:
- spermatogenic failure 30 (Strong), mode of inheritance: AR
- male infertility with azoospermia or oligozoospermia due to single gene mutation (Supportive), mode of inheritance: AD
- spermatogenic failure 30 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spermatogenic failure 30 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 28536242 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TDRD9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 12 | ||||
missense | 84 | 93 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 5 | 2 | 8 | ||
non coding | 2 | |||||
Total | 3 | 2 | 85 | 14 | 9 |
Highest pathogenic variant AF is 0.0000723
Variants in TDRD9
This is a list of pathogenic ClinVar variants found in the TDRD9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-103928555-A-C | Spermatogenic failure 30 | Uncertain significance (Feb 14, 2020) | ||
14-103928558-G-T | not specified | Uncertain significance (Feb 24, 2022) | ||
14-103928607-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
14-103928619-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
14-103928648-G-T | not specified | Uncertain significance (Nov 10, 2022) | ||
14-103928653-C-T | TDRD9-related disorder | Likely benign (Mar 20, 2019) | ||
14-103928661-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
14-103928703-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
14-103928715-C-T | not specified | Uncertain significance (May 15, 2023) | ||
14-103955669-T-G | not specified | Uncertain significance (May 20, 2024) | ||
14-103955740-T-G | Uncertain significance (-) | |||
14-103955743-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
14-103955744-G-T | not specified | Uncertain significance (Oct 05, 2022) | ||
14-103955765-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
14-103963069-C-T | Benign (Aug 09, 2018) | |||
14-103963088-C-T | TDRD9-related disorder | Benign (Jul 23, 2018) | ||
14-103963116-A-A | Benign (Nov 09, 2018) | |||
14-103965330-T-C | TDRD9-related disorder | Likely benign (Apr 01, 2019) | ||
14-103965348-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
14-103965360-G-A | Spermatogenic failure 30 • not specified | Uncertain significance (Dec 07, 2021) | ||
14-103965430-A-C | not specified | Uncertain significance (Jun 13, 2024) | ||
14-103965443-C-T | TDRD9-related disorder | Likely benign (Dec 16, 2019) | ||
14-103965474-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
14-103965511-G-T | not specified | Uncertain significance (Dec 19, 2023) | ||
14-103965536-A-T | TDRD9-related disorder | Likely benign (Apr 01, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TDRD9 | protein_coding | protein_coding | ENST00000409874 | 36 | 124206 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.27e-15 | 1.00 | 125472 | 0 | 120 | 125592 | 0.000478 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.36 | 530 | 706 | 0.750 | 0.0000382 | 9036 |
Missense in Polyphen | 149 | 227.94 | 0.65367 | 2830 | ||
Synonymous | 0.0220 | 261 | 261 | 0.998 | 0.0000155 | 2590 |
Loss of Function | 4.03 | 36 | 73.2 | 0.492 | 0.00000370 | 938 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00114 | 0.00114 |
Ashkenazi Jewish | 0.0000994 | 0.0000993 |
East Asian | 0.000747 | 0.000707 |
Finnish | 0.000390 | 0.000370 |
European (Non-Finnish) | 0.000507 | 0.000502 |
Middle Eastern | 0.000747 | 0.000707 |
South Asian | 0.000338 | 0.000327 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: ATP-binding RNA helicase required during spermatogenesis (PubMed:28536242). Required to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Acts downstream of piRNA biogenesis: exclusively required for transposon silencing in the nucleus, suggesting that it acts as a nuclear effector in the nucleus together with PIWIL4. {ECO:0000250|UniProtKB:Q14BI7, ECO:0000269|PubMed:28536242}.;
- Disease
- DISEASE: Note=Defects in TDRD9 may be a cause of non-obstructive azoospermia, a disorder characterized by the absence of sperm. Female fertility is not affected. {ECO:0000269|PubMed:28536242}.;
- Pathway
- Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- loftool
- 0.988
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.28
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.455
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.155
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tdrd9
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- male meiotic nuclear division;male meiosis I;multicellular organism development;spermatogenesis;fertilization;negative regulation of transposition;cell differentiation;gene silencing by RNA;piRNA metabolic process;DNA methylation involved in gamete generation
- Cellular component
- nucleus;cytoplasm;piP-body
- Molecular function
- RNA binding;ATP binding;ATPase activity;ATP-dependent 3'-5' RNA helicase activity